Indivior (INDV) names Patrick Barry as CCO
Get Alerts INDV Hot Sheet
Join SI Premium – FREE
Indivior PLC (Nasdaq: INDV) today announced the appointment of
"Patrick is an accomplished and respected commercial leader whose strong track record driving growth in branded medicines make him an excellent addition to the executive team," said
Barry has more than 30 years of commercial leadership experience in the pharmaceutical industry. He brings a track record of building and transforming high-performing commercial organizations to deliver sustained revenue growth across multiple product portfolios.
Prior to joining Indivior, Barry served since 2020 as executive vice president and chief commercial officer for Endo Pharmaceuticals. In this role he led all commercial activities across three
"I am honored to join Indivior at such a pivotal time for the company," said Barry. "Indivior has built a strong foundation and is well-positioned to broaden its leadership position in opioid use disorder. I look forward to working with the team to grow SUBLOCADE and maximize the potential of the Indivior portfolio."
Prior to Endo, Barry spent over two decades at Sanofi with increasing levels of responsibility over a range of senior leadership positions, spanning specialty pharmaceuticals, injectables, medical aesthetics, and branded medicines, with demonstrated success in turnaround scenarios, product launches, and market development.
Barry holds an MBA from Cornell University and a bachelor's degree in public relations and marketing from McKendree University.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Takeda names Julie Kim as president and CEO after shareholder vote
- Nokia and AWS expand collaboration on autonomous network platform
- U.S. Physical Therapy (USPH) Reiterated at Market Outperform by Citizens
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share